Hennion & Walsh Asset Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
CI
ETC
WCM
SCM
CAMG
YIH
P
SOADOR
Hennion & Walsh Asset Management's HRMY Position: Q2 2026 in Review
Hennion & Walsh Asset Management reduced its Harmony Biosciences (HRMY) stake by 51% in Q2 2026, selling an estimated $1.48M and leaving 45,408 shares worth $1.65M. The position accounts for 0.05% of the portfolio, ranked #434.
Hennion & Walsh Asset Management first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.62M in Q4 2025. 51 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.
- Hennion & Walsh Asset Management held 45,408 shares of Harmony Biosciences worth $1.65M as of Q2 2026.
- Hennion & Walsh Asset Management sold 46,946 Harmony Biosciences shares in Q2 2026, an estimated $1.48M.
- Harmony Biosciences made up 0.05% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #434 holding.
- Hennion & Walsh Asset Management first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
- Hennion & Walsh Asset Management's Harmony Biosciences position peaked at $3.62M in Q4 2025.
- 51 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.
Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.